Ansoft (ANST) Tops Q4 EPS by 5c
More News related to ANST
- S&P Announces Changes to U.S. Indices (QCOM for CCU, DVA for CCU, ANSS for TQNT, ECLP for ANST, JBT for PLNR)
- Matrix USA Rating Changes 7/1
- Ansoft (ANST) Tops Q4 EPS by 5c
- S&P Equity Research Downgrades ANSYS (ANSS) to Hold
- Matrix USA Rating Changes 4/4
More News related to Earnings
- Somaxon Pharmaceuticals (SOMX) Surges Ahead of FDA Action Date
- BioMarin Pharmaceutical (BMRN) Announces FDA Grants Orphan Drug Designation for 3,4-DAP
- FDA Approves Cymbalta (LLY) for Treatment of Generalized Anxiety Disorder
- Eurand N.V. (EURX) Announces Availability of ZENPEP
- Spectrum Pharma (SPPI) Phase 3 Apaziquone Enrollment Complete
Ansoft (Nasdaq: ANST) Reports Q4 earnings of $0.43 per share, ex-items, above the consensus of $0.38. Revenues came in at $33.9 million, versus the consensus of $32.5 million.
Ansoft Corporation develops electronic design automation (EDA) software used primarily in technology industry.
Related Categories
EarningsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
